NeuroKaire Featured in The Business Journals: Strategies: Depression doesn’t clock out — a neuroscientist’s guide to managing it at work

Depression affects millions of people worldwide, yet treatment remains deeply personal and often challenging. In this feature for BizWomen, neuroscientist and NeuroKaire co-founder Dr. Talia Cohen Solal shares insights on understanding, managing, and treating depression through both scientific innovation and personalized care.

The article examines how advances in neuroscience are reshaping the way clinicians think about depression, moving beyond one-size-fits-all treatment approaches toward more individualized solutions. Dr. Cohen Solal discusses the importance of understanding the biological differences between patients and how emerging technologies can help support more informed treatment decisions.

The feature also highlights the broader vision behind NeuroKaire and BrightKaire™—bringing precision medicine to psychiatry by leveraging patient-derived neurons, artificial intelligence, and biological data to help identify treatments that are more likely to work for each individual patient. As mental healthcare continues to evolve, the article underscores the growing need for tools that can reduce uncertainty and improve outcomes for those living with depression.

👉 Read the full article

‍